Skip to main content
Clinical Trials/NCT03392259
NCT03392259UnknownNot Applicable

Prospective Validation of Usefulness in Cardiovascular Disease (CVD) Management With CVD Management Solution Based on Interconnection to Hospital Examination

Seoul National University Hospital1 site in 1 country666 target enrollmentStarted: February 19, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
666
Locations
1
Primary Endpoint
Change of 10-year ASCVD risk (10-year ASCVD risk at 6 months - 10-year ASCVD risk at baseline)

Study Overview

Brief Summary

We previously developed the smartphone app (Heart4U) which is coupled with electronic medical record system in Seoul National University Bundang Hospital. In this study, we aim to evaluate clinical usefulness of smartphone app regarding the control of conventional risk factors in patients with history of cardiovascular disease.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
30 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with atherosclerotic cardiovascular diseae
  • •history of cardiovascular disease (acute myocardial infarction, unstable angina, stable angina)
  • •history of revascularization including percutaneous coronary intervention, peripheral angioplasty or bypass surgery
  • •history of stroke
  • •history of peripheral arterial disease presumed to be of atherosclerotic origin
  • •Patients who have smartphone and can use app by themselves
  • •Patients who can speak and read Korean language

Exclusion Criteria

  • •Patients with evidences of delirium, confusion or impaired consciousness
  • •Patients who are not familiar to smartphone or app
  • •Patients who are not supposed to follow the study protocol adequately.

Arms & Interventions

Control group

No Intervention

conventional treatment

App group

Experimental

conventional treatment + use of smartphone app.

Intervention: Smartphone app (Behavioral)

Outcomes

Primary Outcomes

Change of 10-year ASCVD risk (10-year ASCVD risk at 6 months - 10-year ASCVD risk at baseline)

Time Frame: 6 months

delta 10-year ASCVD risk between baseline and 6months, %

Secondary Outcomes

  • Systolic blood pressure(3 & 6 months)
  • App service satisfaction survey(6 months)
  • degree of moderate physical activity(6 months)
  • Diastolic blood pressure(3 & 6 months)
  • lipid profiles (total cholesterol, LDL, HDL)(6 months)
  • body mass index(6 months)
  • smoking rate(6 months)
  • drug compliance(6 months)
  • depression scale questionnaire(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jung-Won Suh

Professor

Seoul National University Hospital

Study Sites (1)

Loading locations...

Similar Trials